Importantly, risdiplam and its related compounds are delivered orally and can penetrate into various tissues, including the brain, spinal cord, and muscle, leading to increased SMN levels in the CNS and muscle of mouse models of both mild (C/C-allele) and severe forms (SMNΔ7) of SMA. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.